全文获取类型
收费全文 | 3807895篇 |
免费 | 318075篇 |
国内免费 | 19467篇 |
专业分类
耳鼻咽喉 | 51112篇 |
儿科学 | 119912篇 |
妇产科学 | 98521篇 |
基础医学 | 595274篇 |
口腔科学 | 103316篇 |
临床医学 | 346126篇 |
内科学 | 674836篇 |
皮肤病学 | 98994篇 |
神经病学 | 318945篇 |
特种医学 | 148815篇 |
外国民族医学 | 294篇 |
外科学 | 584560篇 |
综合类 | 125661篇 |
现状与发展 | 37篇 |
一般理论 | 2364篇 |
预防医学 | 310560篇 |
眼科学 | 90468篇 |
药学 | 267790篇 |
99篇 | |
中国医学 | 15564篇 |
肿瘤学 | 192189篇 |
出版年
2021年 | 58954篇 |
2020年 | 38155篇 |
2019年 | 60696篇 |
2018年 | 75031篇 |
2017年 | 57315篇 |
2016年 | 62975篇 |
2015年 | 77800篇 |
2014年 | 112660篇 |
2013年 | 177779篇 |
2012年 | 109915篇 |
2011年 | 112057篇 |
2010年 | 124294篇 |
2009年 | 126395篇 |
2008年 | 96709篇 |
2007年 | 101032篇 |
2006年 | 110169篇 |
2005年 | 104866篇 |
2004年 | 105463篇 |
2003年 | 95173篇 |
2002年 | 84329篇 |
2001年 | 137243篇 |
2000年 | 130976篇 |
1999年 | 123390篇 |
1998年 | 69442篇 |
1997年 | 66100篇 |
1996年 | 63723篇 |
1995年 | 59248篇 |
1994年 | 53108篇 |
1993年 | 49283篇 |
1992年 | 85426篇 |
1991年 | 81338篇 |
1990年 | 76973篇 |
1989年 | 75181篇 |
1988年 | 68957篇 |
1987年 | 67205篇 |
1986年 | 63485篇 |
1985年 | 62711篇 |
1984年 | 54624篇 |
1983年 | 49200篇 |
1982年 | 43193篇 |
1981年 | 40570篇 |
1980年 | 38006篇 |
1979年 | 44506篇 |
1978年 | 37906篇 |
1977年 | 34480篇 |
1976年 | 31587篇 |
1975年 | 30467篇 |
1974年 | 32247篇 |
1973年 | 30989篇 |
1972年 | 28943篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
141.
142.
Liam Masterson James Howard Jazmina Gonzalez-Cruz Christopher Jackson Catherine Barnett Lewis Overton Howard Liu Rahul Ladwa Fiona Simpson Margie McGrath Ben Wallwork Terry Jones Christian Ottensmeier Melvin L.K. Chua Chris Perry Rajiv Khanna Benedict Panizza Sandro Porceddu Matt Lechner 《International journal of cancer. Journal international du cancer》2020,146(8):2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and characterized by a peritumoural immune infiltrate. Our study aims to review past and on-going clinical trials of monoclonal antibody therapies against the checkpoint inhibitors (e.g. PD1 and CTLA-4), in R/M NPC. All randomized and nonrandomized controlled trials involving immune checkpoint inhibitor interventions for treatment of NPC were included in the study. We utilized a validated “risk of bias” tool to assess study quality. Four separate Phase I–II trials report the potential of PD1 inhibitor treatment for patients with NPC. Within the observed groups, camrelizumab combined with chemotherapy achieved an objective response in 91% of patients as first-line treatment for metastatic NPC (PFS 68% at 1-year) but this was associated with a high rate of grade >3 adverse events (87%; CTCAE version 4.03). The remaining three studies focused on recurrent NPC disease in patients who had received at least one line of prior chemotherapy. Within this group, camrelizumab monotherapy achieved an objective response in 34% of patients (PFS 27% at 1-year; range across all three studies 20.5–34%). No NPC trial has yet reported on specific outcomes for non-PD1 checkpoint inhibitors but 11 on-going studies include alternative targets (e.g. PD-L1/CTLA-4) as combination or monotherapy treatments. In considering checkpoint immunotherapies for NPC, initial results show promise for anti-PD1 interventions. Further phase I–III trials are in progress to clarify clinical outcomes, fully determine safety profiles, and optimize drug combinations and administration schedules. 相似文献
143.
Amy L. Judd Kathryn L. Beck Christopher McKinlay Ashleigh Jackson Cathryn A. Conlon 《Maternal & child nutrition》2020,16(1)
Dietary assessment in infants is challenging but necessary to understand the relationship between nutrition and growth and development. Currently no simple, validated methods exist to assess nutrient intake in New Zealand (NZ) infants. Therefore, this study aimed to assess the relative validity and reproducibility of a Complementary Food Frequency Questionnaire (CFFQ) to determine nutrient intakes of NZ infants. Ninety‐five parent–infant pairs (infant age 10 ± 1 months) completed the CFFQ twice (CFFQ‐1 and CFFQ‐2), 4 weeks apart (to assess reproducibility). A 4‐day weighed food record (4dWFR) was collected between CFFQ administrations (to assess validity). Validity and reproducibility were assessed for intakes of energy and 18 nutrients using Bland–Altman analysis, Pearson's correlation coefficients, cross‐classification, and weighted Kappa (κ). The CFFQ showed acceptable validity: Nutrients from the CFFQ were comparable with the 4dWFR (bias, 9–28%), correlation between methods ranged from r = .18 (saturated fat) to r = .81 (iron; mean r = .52), 54% (mean) of participants were correctly classified (range 39% to 67%), and 7.1% (mean) misclassified into opposite tertiles (range 2.1% to 14.7%). There was acceptable agreement between the CFFQ and 4dWFR (κ = 0.20–0.60). The CFFQ showed good reproducibility: Correlations ranged from r = .34 (folate) to r = .80 (zinc); for 16 nutrients, >50% of participants were correctly classified, and for all nutrients, <10% of participants were grossly misclassified. All nutrients showed acceptable to good agreement (κ > 0.20). The CFFQ has acceptable relative validity and good reproducibility for assessing nutrient intake in NZ infants aged 9–12 months, making it a useful tool for use in future research. 相似文献
144.
姜毅 陆小霞 金润铭 郑跃杰 徐保平 谢正德 刘智胜 林丽开 尚云晓 舒赛男 白燕 陆敏 卢根 邓继岿 罗万军 熊莉娟 刘苗 崔玉霞 叶乐平 高立伟 王永炎 王雪峰 李家福 王天有 蒋荣猛 李兴旺 赵东赤 邵剑波 杨永弘 申昆玲 《中华实用儿科临床杂志》2020,(2):143-150
自2019年12月新型冠状病毒感染暴发以来,我国政府采取了严格的防控措施,国内疫情已得到初步控制,但形势依然严峻,境外多个国家也相继出现疫情。根据世界卫生组织的报告:截至2020年3月5日,全球共报告95333例确诊病例(其中我国累计报告确诊病例80565例),85个国家有确诊病例报告,中国将面临输入性病例的传播风险,这为防治我国儿童的疾病疫情提出了新的挑战[1]。在这次疫情中,与成人病例相比,儿童病例相对较少、症状轻、预后较好。目前国内病例数据显示,18岁以下儿童占所有报告病例的2.4%,尚无死亡病例报告[2]。 相似文献
145.
Widder Randolf A. Lappas Alexandra Rennings Corinna Hild Matthias Roessler Gernot F. Dietlein Thomas S. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2020,258(11):2581-2581
Graefe's Archive for Clinical and Experimental Ophthalmology - The published online version contains mistake as the author's first name and last name have been interchanged as "Hild... 相似文献
146.
147.
148.
149.
150.